The Trump administration is expected to set limits on a popular program that allows international students to work in the U.S. after graduation while remaining on their student visas. The restrictions are likely to make economic woes in the U.S. even worse.
The National Science Foundation awards two SDSC researchers funding to organize COVID-19 information into a knowledge network that integrates health, pathogen, and environmental data to track cases across greater San Diego.
Two new studies led by scientists at Scripps Institution of Oceanography at the University of California San Diego highlight the significance of long-term observations for understanding ocean climate trends and events, including record-shattering marine heatwaves.
UC San Diego Health has deployed a mobile ECMO life support system to help sustain critically-ill patients during the pandemic.
South Korea is a standout in the current battle against COVID-19, largely due to its widespread testing and contact tracing; however, key to its innovation is publicly disclosing detailed information on the individuals who test positive for COVID-19.
The University of California San Diego has been named the nation’s sixth best public university by QS World University Rankings, which released their inaugural list of America’s top universities based on diversity, employability and internationalization on May 20. The first annual QS World Universit
UC San Diego researchers have identified small molecules in the blood of asymptomatic pregnant women that may predict risk for preeclampsia, responsible for a significant proportion of maternal and neonatal deaths, low birth weight and is a primary cause of premature birth.
Researchers from the Colorado School of Mines have been using multiple supercomputers, including SDSC's Comet system, to study certain characteristics of zirconia for wider applications of the super-strong material.
The NIH has launched a major clinical trial to assess the malaria drug hydroxychloroquine and antibiotic azithromycin as a treatment for COVID-19. The trial will recruit 2,000 participants at 30 sites. A Q&A with the trial’s team leader: Davey Smith, MD, of UC San Diego School of Medicine.
Using supercomputers, scientists have developed for the first time a way to screen drugs through their chemical structures for induced arrhythmias.